𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epidermal growth factor receptor (EGFR) expression confers poor prognosis in HER2 positive breast cancers

✍ Scribed by Robinson, Amy; Cain, Henry; Amonkar, Sunil; Hemming, Diane; Browell, David


Book ID
122939419
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
66 KB
Volume
39
Category
Article
ISSN
0748-7983

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Serum epidermal growth factor receptor/H
✍ Christopher Souder; Kim Leitzel; Suhail M. Ali; Laurence Demers; Dean B. Evans; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR, HER‐1, and __erbB__1) is overexpressed in primary breast cancer and had been identified as a poor prognostic factor. ## METHODS. Pretreatment serum EGFR levels were quantified by using an enzyme‐linked immunoadsorbent assay in a